Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-10-21

Clinical Trial Update: Efficacy of Dexpanthenol in Thermic Erythema [Phase 2]

View source ↗

Summary

A Phase 2 trial by Bayer assessed the efficacy of dexpanthenol for thermic erythema and the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dexpanthenol (dexpanthenol)

Snippet

Sponsor: Bayer | Conditions: Erythema | Phase 2 | Status: COMPLETED